Fundraising Fox

Cleave Biosciences

Burlingame, US · Delaware corporation · 2 known investors

cleavetherapeutics.com ↗
Biotech

Founders & leadership

AS
Alfred ScheideggerDirector
MR
Mark RolfeExecutive Officer
PT
Peter ThompsonDirector
LS
Laura ShawverExecutive Officer, Director
LS
Lewis ShusterDirector
CG
Carol GallagherDirector
JR
Jonathan RootDirector
TS
Timothy SmithExecutive Officer
AS
Andrew SchwabDirector
DH
Dennis HennerDirector

Investors · 2

Astellas Venture Management LLCSouth San Francisco · $200K – $5M
Nextech InvestZurich · $648K – $3.2Mvia Alfred Scheidegger · board

Reported raises · per SEC filings

Form D private placements
▶$12MraisedJun 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy BurroughsExecutive Officer, Director
  • Laura ShawverDirector
  • Jonathan RootDirector
  • Andrew SchwabDirector
  • Peter ThompsonDirector
Offering amount
$20.8M
Amount sold
$12M
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26MraisedAug 2016 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alfred ScheideggerDirector
  • Mark RolfeExecutive Officer
  • Peter ThompsonDirector
  • Laura ShawverExecutive Officer, Director
  • Lewis ShusterDirector
  • Carol GallagherDirector
  • Jonathan RootDirector
  • Timothy SmithExecutive Officer
  • Andrew SchwabDirector
  • Dennis HennerDirector
Offering amount
$36.8M
Amount sold
$26M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.